A MULTICENTER, OPEN-LABEL, RANDOMIZED TRIAL OF VONOPRAZAN VERSUS PPI BASED 7-DAY TRIPLE THERAPY FOR THE FIRST-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION

被引：0
|
作者：
Sue, Soichiro
Kuwashima, Hirohumi
Arima, Isao
Ogushi, Marina
Nakao, Satoshi
Naito, Makoto
Komatu, Kazuto
Yamada, Hiroaki
Kaneko, Hiroaki
Tamura, Toshihide
Sasaki, Tomohiko
Kondo, Masaaki
Shibata, Wataru
Maeda, Shin
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31131-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1201
引用
收藏
页码：S250 / S250
页数：1
相关论文
共 50 条
  • [41] 10-Day versus 14-day bismuth quadruple therapy for first-line eradication of Helicobacter pylori infection: a randomised, open-label, non-inferiority trial
    Yang, Er -Hsiang
    Chen, Wei-Ying
    Chiang, Hsueh-Chien
    Li, Chung-Hao
    Wu, I-Hsuan
    Chen, Po -Jun
    Wu, Chung -Tai
    Tsai, Yu -Ching
    Cheng, Wei -Chun
    Huang, Chien-Jui
    Sheu, Bor-Shyang
    Cheng, Hsiu-Chi
    [J]. ECLINICALMEDICINE, 2024, 70
  • [42] Randomized controlled trial: PPI-based triple therapy containing metronidazole versus clarithromycin as first-line treatment for Helicobacter pylori in adolescents and young adults in Japan
    Mabe, Katushiro
    Okuda, Masumi
    Kikuchi, Shogo
    Amagai, Kenji
    Yoshimura, Rie
    Kato, Mototsugu
    Sakamoto, Naoya
    Asaka, Masahiro
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2018, 24 (07) : 538 - 543
  • [43] Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection
    Wong, BCY
    Wong, WM
    Yee, YK
    Hung, WK
    Yip, AWC
    Szeto, ML
    Li, KF
    Lau, P
    Fung, FMY
    Tong, TSM
    Lai, KC
    Hu, WHC
    Yuen, MF
    Hui, CK
    Lam, SK
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (12) : 1959 - 1965
  • [44] A Randomized Controlled Trial Comparing the First-Line Eradication Rate Using Vonoprazan or PPI for Helicobacter pylori Infectious Gastritis
    Maruyama, Masafumi
    Kubota, Daisuke
    Miyajima, Masayuki
    Kimura, Takefumi
    Tokutake, Koujiro
    Imai, Ryujiro
    Fujisawa, Toru
    Mori, Hiromitsu
    Matsuda, Yoshiaki
    Wada, Shuichi
    Kiyosawa, Kendo
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S1269 - S1269
  • [45] Bismuth-Based Quadruple Therapy versus Metronidazole- Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial
    Seo, Seung In
    Lim, Hyun
    Bang, Chang Seok
    Yang, Young Joo
    Baik, Gwang Ho
    Lee, Sang Pyo
    Jang, Hyun Joo
    Kae, Sea Hyub
    Kim, Jinseob
    Kim, Hak Yang
    Shin, Woon Geon
    [J]. GUT AND LIVER, 2022, 16 (05) : 697 - 705
  • [46] Randomized Controlled Trial Comparing 7-Day Triple, 10-Day Sequential, and 7-Day Concomitant Therapies for Helicobacter pylori Infection
    Hsu, Ping-I
    Wu, Deng-Chyang
    Chen, Wen-Chi
    Tseng, Hui-Hwa
    Yu, Hsien-Chung
    Wang, Huay-Min
    Kao, Sung-Shuo
    Lai, Kwok-Hung
    Chen, Angela
    Tsay, Feng-Woei
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (10) : 5936 - 5942
  • [47] Efficacy of 7-day bismuth-based quadruple therapy versus 14-day moxifloxacinbased triple therapy for second-line treatment of Helicobacter Pylori infection
    Kim, S.
    Roh, J.
    Park, M.
    Park, S.
    Moon, W.
    Kim, J.
    Jung, K.
    Seol, S.
    [J]. HELICOBACTER, 2016, 21 : 142 - 142
  • [48] Helicobacter pylori eradication: A randomised comparative trial of 7-day versus 14-day triple therapy
    Sokwala, Ahmed
    Shah, Mahesh V.
    Devani, Smita
    Yonga, Gerald
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2012, 102 (06): : 368 - 371
  • [49] Clinical trial: seven-day vonoprazan- versus 14-day proton pump inhibitor-based triple therapy for first-line Helicobacter pylori eradication
    Ang, Daphne
    Koo, Seok Hwee
    Chan, Yiong Huak
    Tan, Thean Yen
    Soon, Gaik Hong
    Tan, Chin Kimg
    Lin, Kenneth Weicong
    Krishnasamy-Balasubramanian, Jaydeesh-Khanna
    Wong, Yu Jun
    Kumar, Rahul
    Rajesh, R.
    Tan, Yiyuan
    Ong, Peng-Lan Jeannie
    Tan, Yi-Lyn Jessica
    Li, James Weiquan
    Kwek, Andrew Boon-Eu
    Ang, Tiing Leong
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (03) : 436 - 449
  • [50] Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice
    Shichijo, Satoki
    Hirata, Yoshihiro
    Niikura, Ryota
    Hayakawa, Yoku
    Yamada, Atsuo
    Mochizuki, Satoshi
    Matsuo, Keigo
    Isomura, Yoshihiro
    Seto, Motoko
    Suzuki, Nobumi
    Suzuki, Hirobumi
    Yamamoto, Shinzo
    Sugimoto, Takafumi
    Omae, Tomoya
    Okamoto, Makoto
    Watabe, Hirotsugu
    Togo, Goichi
    Takano, Noriyuki
    Fukui, Keisuke
    Ito, Yuri
    Koike, Kazuhiko
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2016, 17 (10) : 670 - 675
12345